LAVAL, Quebec (AP) _ Bellus Health Inc. (BLU) on Wednesday reported a loss of $22.9 million in its third quarter.

The Laval, Quebec-based company said it had a loss of 29 cents per share.

The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 24 cents per share.

The drug developer posted revenue of $4,000 in the period.

Bellus shares have more than doubled since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $7.13, nearly tripling in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BLU at https://www.zacks.com/ap/BLU

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News